- Refinancing transaction with proceeds to be utilized to repurchase or repay the 2026 Convertible Notes prior to or at maturity Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today the pricing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results